AMN Healthcare Services Inc. Files 10-Q for Q2 2024

TL;DR

**AMN HEALTHCARE (AMN) Q2 2024 10-Q FILED - FINANCIALS OUT**

AI Summary

AMN Healthcare Services Inc. filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial performance and position, including its balance sheet, income statement, and cash flow statement for the relevant periods. Specific financial figures and operational details are presented within the report.

Why It Matters

This 10-Q filing provides investors and analysts with a detailed look at AMN Healthcare's financial health and operational performance during the second quarter of 2024, influencing investment decisions.

Risk Assessment

Risk Level: medium — 10-Q filings are standard financial reports, but the specific details within can reveal significant financial performance, risks, or opportunities.

Key Numbers

• 20240630 — Period End Date (Indicates the end of the fiscal quarter reported on.)
• 20240809 — Filing Date (The date the 10-Q was officially submitted to the SEC.)

Key Players & Entities

• AMN HEALTHCARE SERVICES INC (company) — Filer of the 10-Q report
• 20240630 (date) — End of the reporting period
• 20240809 (date) — Filing date of the report
• DALLAS (location) — Company's business and mailing address city

FAQ

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value AMN New York Stock Exchange

Filing Documents

• amn-20240630.htm (10-Q) — 1156KB
• amn-ex311x20240630x10q.htm (EX-31.1) — 11KB
• amn-ex312x20240630x10q.htm (EX-31.2) — 11KB
• amn-ex321x20240630x10q.htm (EX-32.1) — 6KB
• amn-ex322x20240630x10q.htm (EX-32.2) — 6KB
• amn-20240630_g1.jpg (GRAPHIC) — 49KB
• 0001142750-24-000050.txt ( ) — 6405KB
• amn-20240630.xsd (EX-101.SCH) — 32KB
• amn-20240630_cal.xml (EX-101.CAL) — 76KB
• amn-20240630_def.xml (EX-101.DEF) — 135KB
• amn-20240630_lab.xml (EX-101.LAB) — 505KB
• amn-20240630_pre.xml (EX-101.PRE) — 348KB
• amn-20240630_htm.xml (XML) — 1115KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION 1. Condensed Consolidated Financial Statements (unaudited): 1 Condensed Consolidated Balance Sheets, As of June 3 0 , 2024 and December 31, 2023 1 Condensed Consolidated Statements of Comprehensive Income, For the Three and Six Months Ended June 3 0 , 2024 and 2023 2 Condensed Consolidated Statements of Stockholders' Equity, For the Six Months Ended June 3 0 , 2024 and 2023 3 Condensed Consolidated Statements of Cash Flows, For the Six Months Ended June 3 0 , 2024 and 2023 4 Notes to Unaudited Condensed Consolidated Financial Statements 6 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 17 3. Quantitative and Qualitative Disclosures about Market Risk 26 4. Controls and Procedures 26

- OTHER INFORMATION

PART II - OTHER INFORMATION 1. Legal Proceedings 27 1A. Risk Factors 27 2. Unregistered Sales of Equity Securities and Use of Proceeds 27 3. Defaults Upon Senior Securities 27 4. Mine Safety Disclosures 27 5. Other Information 27 6. Exhibits 28

Signatures

Signatures 29 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Condensed Consolidated Financial Statements

Item 1. Condensed Consolidated Financial Statements AMN HEALTHCARE SERVICES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited and in thousands, except par value) June 30, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 48,038 $ 32,935 Accounts receivable, net of allowances of $ 33,407 and $ 32,233 at June 30, 2024 and December 31, 2023, respectively 508,913 623,488 Accounts receivable, subcontractor 81,296 117,703 Prepaid expenses 19,673 21,889 Other current assets 46,837 45,670 Total current assets 704,757 841,685 Restricted cash, cash equivalents and investments 71,749 68,845 Fixed assets, net of accumulated depreciation of $ 322,283 and $ 285,081 at June 30, 2024 and December 31, 2023, respectively 197,059 191,385 Other assets 256,951 236,796 Goodwill 1,116,307 1,111,549 Intangible assets, net of accumulated amortization of $ 491,681 and $ 442,052 at June 30, 2024 and December 31, 2023, respectively 424,504 474,134 Total assets $ 2,771,327 $ 2,924,394 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 283,176 $ 343,847 Accrued compensation and benefits 268,354 278,536 Other current liabilities 22,360 33,738 Total current liabilities 573,890 656,121 Revolving credit facility 345,000 460,000 Notes payable, net of unamortized fees and premium 845,280 844,688 Deferred income taxes, net 20,551 23,350 Other long-term liabilities 109,747 108,979 Total liabilities 1,894,468 2,093,138 Commitments and contingencies Stockholders' equity: Preferred stock, $ 0.01 par value; 10,000 shares authorized; none issued and outstanding at June 30, 2024 and December 31, 2023 — — Common stock, $ 0.01 par value; 200,000 shares authorized; 50,613 issued and 38,000 outstanding at June 30, 2024 and 50,423 issued and 37,810 outstanding at December 31, 2023 506 504 Additional paid-in capital 518,313 506,543 Treasury stock, at cost; 12,613 shares at June 30, 2024 and Dece

View Full Filing

View this 10-Q filing on SEC EDGAR